Literature DB >> 7729501

Suppression of natural killer cell activity in mouse spleen lymphocytes by several dopamine receptor antagonists.

S J Won1, Y C Chuang, W T Huang, H S Liu, M T Lin.   

Abstract

The effects of dopaminergic receptor inhibitors such as thiothixine (D1/D2), fluphenazine (D1/D2), trifluoperazine (D1/D2), pimozide (D2), flupenthixol (D1/D2), (+/-)-SKF 83566 (D1), and spiperone (D2) on splenic natural killer (NK) cell cytotoxic activities were assessed in vitro using mouse spleen lymphocytes or enriched NK cells. Both the activities of the splenic NK cell cytotoxicity and the effector-target cell conjugation were suppressed by thiothixine, fluphenazine, and trifluoperazine at concentrations from 2.64 to 14.78 microM. In addition, the augmentation of the cytolytic activity of NK cells induced by interferon-alpha or interleukin-2 was antagonized by pretreatment with these neuroleptic compounds. However, neither the splenic NK cell cytotoxicity nor the effector-target cell conjugation were affected by treatment with other neuroleptic compounds such as pimozide, flupenthixol, (+/-)-SKF 83566, and spiperone. Thus, it appears that neuroleptic compounds such as thiothixine, fluphenazine, and trifluoperazine may act through the mechanisms other than a dopaminergic pathway to affect the NK cell-target cell interaction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729501     DOI: 10.1007/bf01928892

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  23 in total

1.  Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity.

Authors:  K Kuribayashi; S Gillis; D E Kern; C S Henney
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

2.  Mechanisms of human cell-mediated cytotoxicity. I. Modulation of natural killer cell activity by cyclic nucleotides.

Authors:  P Katz; A M Zaytoun; A S Fauci
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

3.  Evidence for a beta-adrenoceptor-mediated regulation of human natural killer cells.

Authors:  K Hellstrand; S Hermodsson; O Strannegård
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

4.  Depletion of catecholamines with alpha-methyl-p-tyrosine suppresses splenic NK cell activity.

Authors:  S J Won; M T Lin
Journal:  Int J Immunopharmacol       Date:  1989

5.  Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody.

Authors:  C Ching; C Lopez
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

6.  Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells.

Authors:  R Suzuki; K Handa; K Itoh; K Kumagai
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

7.  Effects of trifluoperazine, a calmodulin antagonist, on rabbit T- and B-cell responses to mitogens and antigen.

Authors:  A B Stavitsky; J R Dasch; L Astrachan
Journal:  Cell Immunol       Date:  1984-09       Impact factor: 4.868

8.  Interferon induces natural killer cell blastogenesis in vivo.

Authors:  C A Biron; G Sonnenfeld; R M Welsh
Journal:  J Leukoc Biol       Date:  1984-01       Impact factor: 4.962

9.  Regulation of rat natural killing. I. Inhibition of cytolysis and activation by protein synthesis inhibitors.

Authors:  K H Leung; M M Ip
Journal:  Int J Immunopharmacol       Date:  1985

10.  Involvement of CD56 (NKH-1/Leu-19 antigen) as an adhesion molecule in natural killer-target cell interaction.

Authors:  T Nitta; H Yagita; K Sato; K Okumura
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Dopaminergic Regulation of Innate Immunity: a Review.

Authors:  Monica Pinoli; Franca Marino; Marco Cosentino
Journal:  J Neuroimmune Pharmacol       Date:  2017-06-03       Impact factor: 4.147

Review 2.  Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine.

Authors:  Silvia Capellino; Maren Claus; Carsten Watzl
Journal:  Cell Mol Immunol       Date:  2020-06-05       Impact factor: 11.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.